期刊文献+

肺苏颗粒治疗慢性阻塞性肺疾病急性加重期痰热瘀肺证临床研究

Clinical Study on Feisu Granules for the Treatment of Acute Exacerbation of COPD with Syndrome of Phlegm-heat and Blood Stasis of Lung
下载PDF
导出
摘要 目的观察肺苏颗粒治疗慢性阻塞性肺疾病急性加重期(AECOPD)痰热瘀肺证的临床疗效及对患者生活质量、凝血功能和免疫功能的影响。方法采用随机数字表法将120例患者分为观察组和对照组各60例。对照组予常规西医治疗,观察组在对照组基础上予肺苏颗粒口服,每次1袋,每日3次,连续7 d。观察2组临床疗效,比较2组治疗前后中医症状评分、圣乔治呼吸问卷(SGRQ)评分、凝血功能指标(纤维蛋白原、D-二聚体)、免疫功能指标(CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+)),并观察不良反应。结果观察组总有效率为93.10%(54/58),对照组为79.66%(47/59),2组比较差异有统计学意义(P<0.05)。与本组治疗前比较,2组治疗后中医症状积分及咳嗽、喘息、脉络瘀血评分,SGRQ评分均下降(P<0.05);2组治疗后比较,观察组上述评分均低于对照组(P<0.05)。与本组治疗前比较,2组治疗后血浆纤维蛋白原和D-二聚体含量均下降(P<0.05);2组治疗后比较,观察组血浆纤维蛋白原和D-二聚体含量均低于对照组(P<0.05)。与本组治疗前比较,2组治疗后外周血CD4^(+)和CD4^(+)/CD8^(+)均显著升高,CD8^(+)显著降低(P<0.05);2组治疗后比较,观察组外周血CD4^(+)和CD4^(+)/CD8^(+)高于对照组,CD8^(+)低于对照组(P<0.05)。2组均未出现药物相关的不良反应。结论在常规西医治疗基础上联合肺苏颗粒治疗AECOPD痰热瘀肺证可显著提高临床疗效,改善患者生活质量,利于凝血功能恢复,并增强细胞免疫功能。 Objective To observe the clinical efficacy of Feisu Granules,and its effects on quality of life,coagulation and immune function in acute exacerbation of chronic obstructive pulmonary disease(AECOPD)with syndrome of phlegm-heat and blood stasis of lung.Methods Totally 120 AECOPD patients were divided into observation group and control group according to random number table method,with 60 cases in each group.The control group was given conventional Western medicine treatment,and the observation group received Feisu Granules treatment on the basis of the control group,one bag each time,three times a day,orally.The treatment for both groups lasted for 7 d.The clinical efficacy of both groups were observed.TCM symptom scores,St.George’s respiratory questionnaire(SGRQ)score,coagulation function indexes(fibrinogen,D-dimer),and immune function indexes(CD4^(+),CD8^(+),CD4^(+)/CD8^(+))of both groups were compared.The side effects were observed.Results The total effective rate in the observation group(93.10%)was significantly higher than that of the control group(79.66%),with statistical significance(P<0.05).Compared with before treatment,TCM symptom scores,scores of cough,wheezing,venous congestion,and SGRQ score decreased in both groups after treatment(P<0.05);after treatment,the observation group had lower above scores than the control group(P<0.05).Compared with before treatment,both groups showed a decrease in plasma fibrinogen and D-dimer levels after treatment(P<0.05);after treatment,the observation group showed lower levels of plasma fibrinogen and D-dimer compared with the control group(P<0.05).Compared with before treatment,the peripheral blood CD4^(+)and CD4^(+)/CD8^(+)levels in both groups significantly increased after treatment,while CD8^(+)levels significantly decreased(P<0.05);after treatment,the peripheral blood CD4^(+)and CD4^(+)/CD8^(+)in the observation group were higher than those in the control group,while CD8^(+)was lower than those in the control group(P<0.05).Neither group had any drug-related side effects.Conclusion On the basis of conventional Western medicine,the combination of Feisu Granules in the treatment of AECOPD with syndrome of phlegm-heat and blood stasis of lung can significantly improve clinical efficacy,improve patient quality of life,facilitate coagulation function recovery,and enhance cellular immune function.
作者 陈云坤 李芹 魏恩垚 张凤 王杰 李秀华 刘煌 CHEN Yunkun;LI Qin;WEI Enyao;ZHANG Feng;WANG Jie;LI Xiuhua;LIU Huang(Chongqing Traditional Chinese Medicine Hospital,Chongqing 400021,China)
机构地区 重庆市中医院
出处 《中国中医药信息杂志》 CAS CSCD 2024年第4期170-174,共5页 Chinese Journal of Information on Traditional Chinese Medicine
基金 重庆市科卫联合中医药技术创新与应用发展项目(2020ZY3613) 重庆市名老中医药专家李秀华传承工作室建设项目(2020年)。
关键词 肺苏颗粒 慢性阻塞性肺疾病 痰热瘀肺证 疗效 免疫功能 Feisu Granules chronic obstructive pulmonary disease syndrome of phlegm-heat and blood stasis of lung efficacy immune function
  • 引文网络
  • 相关文献

参考文献5

二级参考文献56

共引文献1915

相关主题

;
使用帮助 返回顶部